 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 03/11/2024 |
$3.15 |
$3.15 |
$3.00 |
$3.03 |
3.46M | | 03/12/2024 |
$3.03 |
$3.04 |
$3.00 |
$3.00 |
89.10K | | 03/13/2024 |
$3.02 |
$3.05 |
$3.00 |
$3.02 |
227.50K | | 03/14/2024 |
$3.02 |
$3.09 |
$3.02 |
$3.09 |
153.10K | | 03/15/2024 |
$3.03 |
$3.09 |
$3.00 |
$3.02 |
980.50K |
|
|
| Cyteir Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing the oncology medicines that inhibit deoxyribonucleic acid damage repair and cause cancer cell death in specific subsets of cancer patients through a therapeutic strategy known as synthetic lethality. Co.'s primary program, CYT-0851, was identified through a phenotypic screening strategy that exploited a synthetic lethality between cytidine deaminases (CD) overexpression and homologous recombination inhibition. The screen was designed to select for compounds that induced synthetic lethality in CD-overexpressing cancer cells while sparing normal cells. | |
|
Cyteir Therapeutics (CYT) has the following price history information. Looking back at CYT historical stock prices for the last five trading days, on March 11, 2024, CYT opened at $3.15, traded as high as $3.15 and as low as $3.00, and closed at $3.03. Trading volume was a total of 3.46M shares. On March 12, 2024, CYT opened at $3.03, traded as high as $3.04 and as low as $3.00, and closed at $3.00. Trading volume was a total of 89.10K shares. On March 13, 2024, CYT opened at $3.02, traded as high as $3.05 and as low as $3.00, and closed at $3.02. Trading volume was a total of 227.50K shares. On March 14, 2024, CYT opened at $3.02, traded as high as $3.09 and as low as $3.02, and closed at $3.09. Trading volume was a total of 153.10K shares. On March 15, 2024, CYT opened at $3.03, traded as high as $3.09 and as low as $3.00, and closed at $3.02. Trading volume was a total of 980.50K shares.
CYT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cyteir Therapeutics shares, starting with a $10,000 purchase of CYT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/18/2021 |
|
| End date: |
03/15/2024 |
|
| Start price/share: |
$17.40 |
|
| End price/share: |
$3.02 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-82.64% |
|
| Average Annual Total Return: |
-47.19% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,736.04 |
|
| Years: |
2.74 |
|
|
|
| Date |
Close |
| 03/11/2024 | $3.03 | | 03/12/2024 | $3.00 | | 03/13/2024 | $3.02 | | 03/14/2024 | $3.09 | | 03/15/2024 | $3.02 |
|
|
Free CYT Email Alerts:
